Biogen, Ionis shares rally as muscle drug for infants hits its goal
Biogen and Ionis Pharmaceuticals shares soared after an analysis showed a drug for a deadly muscle disorder in infants met its main goal.
Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer